aripiprazole

Biomarkers to Enhance Early Schizophrenia Treatment

Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications

Cerebellum-based Imaging Neural Markers for Antipsychotic Response

Switching Medication to Treat Schizophrenia

Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD).

Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)

A Study Assessing the Efficacy and Safety of HS-10380 in Hospitalized Adults With Acute Schizophrenia

Substance Misuse To Psychosis for Stimulants

Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD)

Atypical Antipsychotic-induced Mitochondrial Dysfunction in Patients With Schizophrenia

Aripiprazole in Body Focused Repetitive Behaviors

Whole Blood and Plasma Sample Collection for the Development of Antipsychotic Immunoassays From Participants Taking Aripiprazole, Olanzapine, Paliperidone, or Risperidone

RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder

Switching Medication and Augmentation Strategies for SSRI-Resistant Adolescent Depression（SMART-I)

A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform

Safety and Efficacy of Brexpiprazole in the Treatment of Schizophrenia

Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis

The Impact of Aripiprazole Long-acting on Myelin and Cognition in the Onset of Schizophrenia

A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication

Aripiprazole for Bipolar Disorder and Alcohol Use Disorder